Hi Lina,
I think your research is very interesting. I might be wrong but I thought of it as a kind of an "artificial" precision medicine. My work is in the area of brain tumors and I definitely can appreciate the value of this implementation since, choosing a treatment is something that the clinicians struggle with on a daily basis. As a junior researcher in this field I also realize the limitations that "conventional methods" can have in our populations, since we work with very small Ns, the treatment options available are limited and it's difficult to generalize results. But I think that methods like the one you are proposing would be very helpful in these kind of settings.
What are the populations that these algorithms have tested?
Have these methods incorporate precision medicine outcomes (i.e. gene mapping results or genetic profiles)?
I look forward to hear more from this research.